Word

BIOMATION

Status

Pending

Status Code

686

Status Date

Tuesday, March 12, 2024

Serial Number

98254291

Mark Type

4000

Filing Date

Friday, November 3, 2023

Published for Opposition

Tuesday, March 12, 2024

Trademark Owner History

DEKA Research & Development Corp. - Owner At Publication

Classifications

40 Manufacturing advisory services; biomanufacturing for others, namely, manufacturing of biologics, cells, scaffolds, matrices, tissues, organs and related biological materials; 3D printing services for others; Custom 3D printing services; renting of 3D printers; creation of customized three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting for others; Bioprinting for others; Research in the field of three-dimensional (3D) printing in the nature of bioprinting for others; Technical consultancy in the field of rapid prototype fabrication of new products for others; Providing technical information in the field of manufacturing biomaterials, regenerative medicine products, biologics, cells, scaffolds, matrices, tissues, organs and related biological materials, and their manufacturing; processing of medical materials, namely, custom fabrication, and assembly of biologics, cells, scaffolds, matrices, tissues, organs and related biological materials for research, development, and medical purposes; biologic manufacturing for others, namely, isolating and processing biologic tissue products from human tissues for use in regenerative medicine; biologic manufacturing, namely, isolating and processing biologic products from human tissues for use in regenerative medicine

9 Automated and semi-automated cell culture apparatus for laboratory use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Laboratory equipment and supplies, namely, incubators for cell culturing, cell therapy, tissue manufacturing and organ manufacturing and electronic monitors for monitoring cell culture incubators; Disposable plastic bioreactors for cell culturing; Biochips for the production of three-dimensional living tissues, organs and autologous cell samples for research or scientific purposes; Bioreactors for cell culturing for laboratory use; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers for the purpose of laboratory research; Automated and semi-automated medical equipment for the preparation of autologous and allogeneic biological cell therapies for medical purposes, namely, a fully integrated system composed primarily of computers, electronic sensors, and monitors, plastic tubing, syringes, and pumps, and metal containers, bottles, and heating plates for use in the creation of biological cell therapies, organs, tissues and autologous cell samples for medical purposes; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of medical and scientific research

7 Biomanufacturing devices for engineering of three-dimensional tissues, organs, and autologous cell samples, namely, 3D bioprinters; Fabrication devices for rejuvenation of tissues, organs, autologous cell samples, namely, tissue rejuvenation devices in the nature of bioprinters

10 Automated and semi-automated cell culture apparatus for medical use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Medical devices, namely, electromechanical fluidic instruments, and other similar or related devices, which process complex human body fluids for the purpose of separating human cell culture samples, and separating fluids; Medical instruments for processing of human body fluids in the nature of human cell samples, blood, and plasma, and the isolation and concentration of components thereof for the purpose of treating degenerative diseases, and chronic diseases; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of therapeutic regenerative medical treatment, blood transfusions, and cell transfusions

42 Scientific and technological services, namely, scientific research, analysis, design and testing in the field of regenerative medicine, automated production systems for regenerative medicine, biologics, cells, scaffolds, matrices, tissues, organs and related biological materials

Trademark Events

Mar 12, 2024

Official Gazette Publication Confirmation E-Mailed

Mar 12, 2024

Published For Opposition

Feb 21, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 21, 2024

Notification Of Notice Of Publication E-Mailed

Feb 1, 2024

Approved For Pub - Principal Register

Feb 1, 2024

Examiner's Amendment Entered

Feb 1, 2024

Notification Of Examiners Amendment E-Mailed

Feb 1, 2024

Examiners Amendment E-Mailed

Feb 1, 2024

Examiners Amendment -Written

Jan 29, 2024

Previous Allowance Count Withdrawn

Jan 16, 2024

Withdrawn From Pub - Og Review Query

Jan 2, 2024

Approved For Pub - Principal Register

Jan 2, 2024

Examiner's Amendment Entered

Jan 2, 2024

Notification Of Examiners Amendment E-Mailed

Jan 2, 2024

Examiners Amendment E-Mailed

Jan 2, 2024

Examiners Amendment -Written

Dec 1, 2023

Teas/Email Correspondence Entered

Dec 1, 2023

Correspondence Received In Law Office

Dec 1, 2023

Teas Response To Office Action Received

Nov 30, 2023

Notification Of Non-Final Action E-Mailed

Nov 30, 2023

Non-Final Action E-Mailed

Nov 30, 2023

Non-Final Action Written

Nov 28, 2023

Assigned To Examiner

Nov 27, 2023

New Application Office Supplied Data Entered

Nov 7, 2023

New Application Entered